Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cynthia Désaulniers-Langevin"'
Autor:
Marie-Lyn Goyer, Cynthia Desaulniers-Langevin, Anthony Sonn, Georgio Mansour Nehmo, Véronique Lisi, Basma Benabdallah, Noël J.-M. Raynal, Christian Beauséjour
Publikováno v:
Cells, Vol 13, Iss 10, p 849 (2024)
The risk of aberrant growth of induced pluripotent stem cell (iPSC)-derived cells in response to DNA damage is a potential concern as the tumor suppressor genes TP53 and CDKN2A are transiently inactivated during reprogramming. Herein, we evaluate the
Externí odkaz:
https://doaj.org/article/b05aeb8b457a46348ea195e1c8cc302c
Autor:
Basma Benabdallah, Cynthia Désaulniers‐Langevin, Marie‐Lyn Goyer, Chloé Colas, Chantale Maltais, Yuanyi Li, Jean V. Guimond, Jacques P. Tremblay, Elie Haddad, Christian Beauséjour
Publikováno v:
Stem Cells Translational Medicine, Vol 10, Iss 2, Pp 267-277 (2021)
Abstract It is still unclear if immune responses will compromise the large‐scale utilization of human induced pluripotent stem cells (hiPSCs)‐derived cell therapies. To answer this question, we used humanized mouse models generated by the adoptiv
Externí odkaz:
https://doaj.org/article/6064d61e1311429daf099fa21ffebf10
Autor:
Basma Benabdallah, Cynthia Désaulniers-Langevin, Chloé Colas, Yuanyi Li, Guy Rousseau, Jean V. Guimond, Elie Haddad, Christian Beauséjour
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The safe utilization of induced pluripotent stem cell (iPSC) derivatives in clinical use is attributed to the complete elimination of the risk of forming teratomas after transplantation. The extent by which such a risk exists in immune-competent host
Externí odkaz:
https://doaj.org/article/120cee26c42148d0b6621de0dc86b937
Autor:
Jacques P. Tremblay, Basma F. Benabdallah, Elie Haddad, Chantale Maltais, Cynthia Désaulniers-Langevin, Marie-Lyn Goyer, Chloé Colas, Yuanyi Li, Christian Beauséjour, Jean V. Guimond
Publikováno v:
Stem Cells Translational Medicine, Vol 10, Iss 2, Pp 267-277 (2021)
Stem Cells Translational Medicine
Stem Cells Translational Medicine
It is still unclear if immune responses will compromise the large‐scale utilization of human induced pluripotent stem cells (hiPSCs)‐derived cell therapies. To answer this question, we used humanized mouse models generated by the adoptive transfe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65682629cb24b7c425648129f84e8ae9
https://doi.org/10.1002/sctm.19-0452
https://doi.org/10.1002/sctm.19-0452
Autor:
Jean V. Guimont, Yuanyi Li, Chloé Colas, Chantale Maltais, Christian Beauséjour, Basma F. Benabdallah, Cynthia Désaulniers-Langevin, Elie Haddad, Marie-Lyn Goyer, Jacques P. Tremblay
It is still unclear if immune responses will compromise the large scale utilization of cell therapies derived from human induced pluripotent stem cells (hiPSCs). To answer this question, we used humanized mouse models generated by the adoptive transf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448fba22b554faf6b91a1feb64194ef6
